MoneyWorks4Me

Kopran reports Profit after tax of Rs 74.88 Mln, in the September 2020 quarter

28 Oct 2020 Evaluate
The revenue for the September 2020 quarter is pegged at Rs. 470.73 millions against Rs. 482.85 millions recorded during the year-ago period.Net Profit for the quarter ended September 2020 zoomed to 207.77% from Rs. 24.33 millions to Rs. 74.88  millions.The company reported a good operating profit of 126.69 millions compared to 56.38 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202009 201909 % Var 202009 201909 % Var 202003 201903 % Var
Sales 470.73 482.85 -2.51 1043.06 860.27 21.25 1792.91 1966.46 -8.83
Other Income 32.64 15.99 104.13 56.59 35.28 60.40 19.90 30.96 -35.72
PBIDT 126.69 56.38 124.71 235.09 98.56 138.52 251.67 259.19 -2.90
Interest 11.15 12.47 -10.59 25.72 25.83 -0.43 59.62 54.55 9.29
PBDT 115.54 43.91 163.13 209.37 72.73 187.87 192.05 204.64 -6.15
Depreciation 10.49 9.45 11.01 20.05 17.43 15.03 34.72 31.06 11.78
PBT 105.05 34.46 204.85 189.32 55.30 242.35 157.33 173.58 -9.36
TAX 30.17 10.13 197.83 54.24 15.86 241.99 45.13 43.87 2.87
Deferred Tax 11.72 2.70 334.07 21.27 4.55 367.47 17.12 9.11 87.93
PAT 74.88 24.33 207.77 135.08 39.44 242.49 112.20 129.71 -13.50
Equity 432.49 432.49 0.00 432.49 432.49 0.00 432.49 432.50 0.00
PBIDTM(%) 26.91 11.68 130.49 22.54 11.46 96.72 14.04 13.18 6.50
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..